Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …

Simple Summary Lung cancer is the leading cause of cancer-related death worldwide, with
an average 5-year survival rate of approximately 15%. Among the multiple histological type …

Lung cancer is the most often diagnosed cancer in the world and the most frequent cause of
cancer death. The prognosis for lung cancer is relatively poor and 75% of patients are …

Simple Summary Despite an initial response to therapy, many lung cancer patients
inevitably develop resistance to therapy leading to decreased duration of response and …

Nowadays, lung cancer is still the deadliest oncological disease in the world. Among them,
non-small cell lung cancer (NSCLC) accounts for 80%∼ 85% of all lung cancers, and its 5 …

Recent statistics on lung cancer, including the steady decline of advanced diseases and the
dramatically increasing detection of early-stage diseases and indeterminate pulmonary …

Background Long intergenic non-protein coding RNA 1140 (LINC01140), a long non-coding
RNA, is highly expressed in various cancers; however, its biological functions in lung cancer …

Abstract Background and Objective The early diagnosis of Non-small cell lung cancer
(NSCLC) is of prime importance to improve the patient's survivability and quality of life …

Lung adenocarcinoma (LUAD) is a highly heterogeneous disease that ranks first in
morbidity and mortality. Abnormal arginine metabolism is associated with inflammatory lung …

Background MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression.
Differential miRNA expression, which is widely shown to be associated with the …